IN191359B - - Google Patents

Info

Publication number
IN191359B
IN191359B IN607DE1999A IN191359B IN 191359 B IN191359 B IN 191359B IN 607DE1999 A IN607DE1999 A IN 607DE1999A IN 191359 B IN191359 B IN 191359B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Shakti Nath Upadhyay
Vikas Madan
Original Assignee
Nat Inst Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Immunology filed Critical Nat Inst Immunology
Priority to IN607DE1999 priority Critical patent/IN191359B/en
Priority to US09/339,759 priority patent/US6251383B1/en
Publication of IN191359B publication Critical patent/IN191359B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN607DE1999 1999-04-20 1999-04-20 IN191359B (forum.php)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN607DE1999 IN191359B (forum.php) 1999-04-20 1999-04-20
US09/339,759 US6251383B1 (en) 1999-04-20 1999-06-24 Method for ex-vivo expansion of hematopoietic cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN607DE1999 IN191359B (forum.php) 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
IN191359B true IN191359B (forum.php) 2003-11-29

Family

ID=11090508

Family Applications (1)

Application Number Title Priority Date Filing Date
IN607DE1999 IN191359B (forum.php) 1999-04-20 1999-04-20

Country Status (2)

Country Link
US (1) US6251383B1 (forum.php)
IN (1) IN191359B (forum.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046373A1 (en) 2000-12-06 2002-06-13 Hariri Robert J Method of collecting placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2336300B1 (en) 2001-02-14 2015-07-08 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
KR20050008757A (ko) * 2002-05-30 2005-01-21 셀진 코포레이션 세포 분화를 조절하고 골수증식성 질환 및 골수형성이상증후군을 치료하기 위하여 ｊｎｋ 또는 ｍｋｋ 저해제를사용하는 방법
WO2004111184A2 (en) * 2002-10-04 2004-12-23 Embiosis Pharmaceuticals Method of amplifying metabolically inactive bacteria
KR20050086780A (ko) 2002-11-26 2005-08-30 안트로제네시스 코포레이션 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
WO2005074959A1 (en) * 2004-02-05 2005-08-18 Access Business Group International Llc Anti-allergy composition and related method
ES2431522T3 (es) * 2004-04-09 2013-11-26 Piramal Enterprises Limited Extracto herbal para trastornos renales
US20060045923A1 (en) * 2004-09-02 2006-03-02 Lal Hingorani Composition containing tinospora cordifolia and process for obtaining same
RS53210B (sr) 2005-10-13 2014-08-29 Anthrogenesis Corporation Imunomodulacija upotrebom matičnih ćelija placente
PL2471907T3 (pl) 2005-12-29 2019-07-31 Celularity, Inc. Populacje komórek macierzystych łożyska
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
EP2108043A4 (en) * 2007-01-18 2010-04-21 Suomen Punainen Risti Veripalv NEW METHODS AND REAGENTS FOR THE PRODUCTION OF CELLS
CN103356710A (zh) 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
WO2008101215A1 (en) 2007-02-16 2008-08-21 Varian Medical Systems Technologies, Inc. Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
KR20210127819A (ko) 2007-09-28 2021-10-22 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
US20100120142A1 (en) 2008-07-11 2010-05-13 Suomen Punainen Risti Veripalvelu Culture of human embryonic cells
RU2563518C2 (ru) 2008-08-20 2015-09-20 Антродженезис Корпорейшн Улучшенная клеточная композиция и способы ее получения
KR20230031991A (ko) 2008-08-20 2023-03-07 셀룰래리티 인코포레이티드 단리된 태반 세포를 사용한 뇌졸중 치료
AU2009283161A1 (en) 2008-08-22 2010-02-25 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
BRPI0922184A2 (pt) 2008-11-19 2020-08-18 Anthrogenesis Corporation célula isolada, população isolada de células, matriz ou estrutura sintética permanente ou decelularizada degradável, e , método para tratar um indivíduo
US8586360B2 (en) * 2009-07-02 2013-11-19 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
MX2012008636A (es) 2010-01-26 2012-10-15 Anthrogenesis Corp Tratamiento de canceres relacionados con el hueso utilizando celulas madre placenterias.
AU2011237747B2 (en) 2010-04-07 2015-07-23 Celularity Inc. Angiogenesis using placental stem cells
AU2011237743A1 (en) 2010-04-08 2012-11-01 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
BR112013000822B1 (pt) 2010-07-13 2021-02-23 Anthrogenesis Corporation Método in vitro em duas etapas para a produção de uma população decélulas exterminadoras naturais (nk) ativadas
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
DK2714059T3 (en) 2011-06-01 2019-01-21 Celularity Inc TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
WO2014123879A1 (en) 2013-02-05 2014-08-14 Anthrogenesis Corporation Natural killer cells from placenta
CN120924475A (zh) 2014-09-18 2025-11-11 北卡罗来纳大学 哺乳动物肺球体和肺球体细胞及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis

Also Published As

Publication number Publication date
US6251383B1 (en) 2001-06-26

Similar Documents

Publication Publication Date Title
BE2013C001I2 (forum.php)
JP2002526326A5 (forum.php)
JP2002519497A5 (forum.php)
JP2002512436A5 (forum.php)
BRPI0017527B8 (forum.php)
JP2002527967A5 (forum.php)
JP2002524942A5 (forum.php)
JP2002507030A5 (forum.php)
JP2002526000A5 (forum.php)
JP2002532913A5 (forum.php)
IN189332B (forum.php)
BRPI0001542A2 (forum.php)
IN191359B (forum.php)
JP2002519505A5 (forum.php)
JP2002531865A5 (forum.php)
JP2002502729A5 (forum.php)
JP2002515361A5 (forum.php)
BRPI0017522A2 (forum.php)
JP2001012573A5 (forum.php)
JP2002507836A5 (forum.php)
BRPI0303609A (forum.php)
BRPI9917761A2 (forum.php)
GB9911345D0 (forum.php)
FR2771718A3 (forum.php)
GR20000200007U (forum.php)